Lista de obras -

Absence of bilateral vision loss from amiodarone: a randomized trial

artículo científico publicado en 2007

Age and gender differences in quality of care and outcomes for patients with ST-segment elevation myocardial infarction

artículo científico publicado en 2012

Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial

artículo científico publicado en 2015

Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention

artículo científico publicado en 2015

Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%.

artículo científico publicado en 2014

Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: observations from "Assessment of Pexelizumab in Acute Myocardial Infarction".

artículo científico publicado en 2011

Care Transitions After Acute Myocardial Infarction for Transferred-In Versus Direct-Arrival Patients

artículo científico publicado en 2016

Changing preferences for survival after hospitalization with advanced heart failure

artículo científico publicado en 2008

Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial

artículo científico publicado en 2014

Comparative Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention in Women

artículo científico publicado en 2016

Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention

Differences in Short- and Long-Term Outcomes Among Older Patients With ST-Elevation Versus Non-ST-Elevation Myocardial Infarction With Angiographically Proven Coronary Artery Disease

artículo científico publicado en 2016

Disease Burden Following Non-Cardioembolic Minor Ischemic Stroke or High-Risk TIA: A GWTG-Stroke Study

artículo científico publicado en 2020

Effectiveness of cardiac rehabilitation among older patients after acute myocardial infarction

artículo científico publicado en 2015

Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial).

artículo científico publicado en 2017

Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation.

artículo científico publicado en 2013

Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF.

artículo científico publicado en 2013

Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: The Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial F

article by Sameer Bansilal et al published October 2015 in American Heart Journal

Efficacy and safety of rivaroxaban in patients with heart failure and nonvalvular atrial fibrillation: insights from ROCKET AF.

artículo científico

Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

artículo científico publicado en 2008

End of study transition from study drug to open-label vitamin K antagonist therapy: the ROCKET AF experience

artículo científico publicado en 2013

Exercise training and implantable cardioverter-defibrillator shocks in patients with heart failure: results from HF-ACTION (Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing)

artículo científico publicado en 2013

High-sensitivity C-reactive protein elevation in patients with prior myocardial infarction in the United States

artículo científico publicado en 2018

Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial

artículo científico publicado en 2014

Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial

artículo científico publicado en 2013

Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial

artículo científico publicado en 2009

Implantable cardioverter defibrillator therapy in patients with prior coronary revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

artículo científico publicado en 2008

Lipid Testing and Statin Dosing After Acute Myocardial Infarction

artículo científico publicado en 2018

Lipid profile, lipid-lowering medications, and intracerebral hemorrhage after tPA in get with the guidelines-stroke

artículo científico publicado en 2013

Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population

artículo científico publicado en 2009

Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX-AMI).

artículo científico publicado en 2010

Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)

artículo científico publicado en 2010

Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban

artículo científico publicado en 2016

No benefit of a dual coil over a single coil ICD lead: evidence from the Sudden Cardiac Death in Heart Failure Trial

artículo científico publicado en 2013

Non-evidence-based ICD implantations in the United States

artículo científico publicado en 2011

Novel application of approaches to predicting medication adherence using medical claims data

artículo científico publicado en 2019

On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF.

artículo científico

Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

artículo científico publicado en 2007

Outcomes According to Cardiac Catheterization Referral and Clopidogrel Use Among Medicare Patients With Non-ST-Segment Elevation Myocardial Infarction Discharged Without In-hospital Revascularization

artículo científico publicado en 2016

Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Preven

artículo científico publicado en 2013

Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention o

artículo científico publicado en 2014

Participation in Cardiac Rehabilitation Programs Among Older Patients After Acute Myocardial Infarction

artículo científico publicado en 2015

Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study

artículo científico publicado en 2008

Primary prevention implantable cardioverter-defibrillators and survival in older women

artículo científico publicado en 2014

Primary prevention implantable cardioverter-defibrillators in older racial and ethnic minority patients

artículo científico publicado en 2014

Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial

artículo científico publicado en 2008

Prior Antithrombotic Use Is Associated With Favorable Mortality and Functional Outcomes in Acute Ischemic Stroke

artículo científico publicado en 2016

Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support

artículo científico publicado en 2016

Prognostic importance of defibrillator shocks in patients with heart failure

artículo científico publicado en 2008

Racial/Ethnic and Sex Differences in Emergency Medical Services Transport Among Hospitalized US Stroke Patients: Analysis of the National Get With The Guidelines-Stroke Registry

artículo científico publicado en 2015

Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

artículo científico publicado en 2013

Relation of Admission Blood Pressure to In-hospital and 90-Day Outcomes in Patients Presenting With Transient Ischemic Attack

scientific article published on 11 January 2019

Relationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: results from the ROCKET AF trial

artículo científico publicado en 2014

Reply: circadian variations of ventricular arrhythmias and sleep-disordered breathing in HF patients

artículo científico publicado en 2014

Reply: rapid rate nonsustained ventricular tachycardia found on ICD interrogation: relationship of RR-NSVT to outcomes in the SCD-HeFT trial

artículo científico publicado en 2013

Representativeness of RELAX-AHF clinical trial population in acute heart failure.

artículo científico publicado en 2014

Response by Hess et al to Letter Regarding Article, “Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Fai

Response to Letter Regarding Article, "Comparative Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention in Women".

artículo científico publicado en 2016

Response to Letter Regarding Article, “Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure: Analysis From the Sudden Cardiac Death in Heart Failure Trial”

Response to Letter Regarding Article, “Risk of Thromboembolism in Heart Failure: An Analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)”

Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation".

artículo científico publicado en 2014

Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

artículo científico publicado en 2007

Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure

artículo científico publicado en 2006

Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention

artículo científico publicado en 2016

Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings from the Get With The Guidelines-Heart Failure Program

artículo científico publicado en 2016

Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)

artículo científico publicado en 2007

Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials

artículo científico publicado en 2013

Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study

artículo científico publicado en 2008

The association of pre- and posthospital medication adherence in myocardial infarction patients

artículo científico publicado en 2018

Thyroid function in heart failure and impact on mortality

artículo científico publicado en 2013

Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention

artículo científico publicado en 2009

Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atr

artículo científico publicado en 2017

Treatment, Outcomes, and Adherence to Medication Regimens Among Dual Medicare-Medicaid-Eligible Adults With Myocardial Infarction

artículo científico publicado en 2016

Trends in use of implantable cardioverter-defibrillator therapy among patients hospitalized for heart failure: have the previously observed sex and racial disparities changed over time?

artículo científico publicado en 2012

Unexpected deviation in circadian variation of ventricular arrhythmias: the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

artículo científico publicado en 2014

Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial

artículo científico publicado en 2014

Use and predictors of heart failure disease management referral in patients hospitalized with heart failure: insights from the Get With the Guidelines Program

artículo científico publicado en 2011

Use of Prescription Smoking Cessation Medications After Myocardial Infarction Among Older Patients in Community Practice

artículo científico publicado en 2017

Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial

artículo científico publicado en 2016

Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

artículo científico publicado en 2014

Utilization of cardiac resynchronization therapy in eligible patients hospitalized for heart failure and its association with patient outcomes

artículo científico publicado en 2017

Value of clinician assessment of hemodynamics in advanced heart failure: the ESCAPE trial

artículo científico publicado en 2008

Venous thromboembolism in the Get With The Guidelines-Stroke acute ischemic stroke population: incidence and patterns of prophylaxis.

artículo científico publicado en 2012

Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

artículo científico publicado en 2007

Lista de obras de

Absence of bilateral vision loss from amiodarone: a randomized trial

Age and gender differences in quality of care and outcomes for patients with ST-segment elevation myocardial infarction

Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial

Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention

Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%.

Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: observations from "Assessment of Pexelizumab in Acute Myocardial Infarction".

Care Transitions After Acute Myocardial Infarction for Transferred-In Versus Direct-Arrival Patients

Changing preferences for survival after hospitalization with advanced heart failure

Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial

Comparative Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention in Women

Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention

Differences in Short- and Long-Term Outcomes Among Older Patients With ST-Elevation Versus Non-ST-Elevation Myocardial Infarction With Angiographically Proven Coronary Artery Disease

Disease Burden Following Non-Cardioembolic Minor Ischemic Stroke or High-Risk TIA: A GWTG-Stroke Study

Effectiveness of cardiac rehabilitation among older patients after acute myocardial infarction

Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial).

Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation.

Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF.

Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: The Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial F

Efficacy and safety of rivaroxaban in patients with heart failure and nonvalvular atrial fibrillation: insights from ROCKET AF.

Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

End of study transition from study drug to open-label vitamin K antagonist therapy: the ROCKET AF experience

Exercise training and implantable cardioverter-defibrillator shocks in patients with heart failure: results from HF-ACTION (Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing)

High-sensitivity C-reactive protein elevation in patients with prior myocardial infarction in the United States

Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial

Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial

Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial

Implantable cardioverter defibrillator therapy in patients with prior coronary revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

Lipid Testing and Statin Dosing After Acute Myocardial Infarction

Lipid profile, lipid-lowering medications, and intracerebral hemorrhage after tPA in get with the guidelines-stroke

Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population

Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX-AMI).

Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)

Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban

No benefit of a dual coil over a single coil ICD lead: evidence from the Sudden Cardiac Death in Heart Failure Trial

Non-evidence-based ICD implantations in the United States

Novel application of approaches to predicting medication adherence using medical claims data

On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF.

Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

Outcomes According to Cardiac Catheterization Referral and Clopidogrel Use Among Medicare Patients With Non-ST-Segment Elevation Myocardial Infarction Discharged Without In-hospital Revascularization

Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Preven

Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention o

Participation in Cardiac Rehabilitation Programs Among Older Patients After Acute Myocardial Infarction

Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study

Primary prevention implantable cardioverter-defibrillators and survival in older women

Primary prevention implantable cardioverter-defibrillators in older racial and ethnic minority patients

Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial

Prior Antithrombotic Use Is Associated With Favorable Mortality and Functional Outcomes in Acute Ischemic Stroke

Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support

Prognostic importance of defibrillator shocks in patients with heart failure

Racial/Ethnic and Sex Differences in Emergency Medical Services Transport Among Hospitalized US Stroke Patients: Analysis of the National Get With The Guidelines-Stroke Registry

Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

Relation of Admission Blood Pressure to In-hospital and 90-Day Outcomes in Patients Presenting With Transient Ischemic Attack

Relationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: results from the ROCKET AF trial

Reply: circadian variations of ventricular arrhythmias and sleep-disordered breathing in HF patients

Reply: rapid rate nonsustained ventricular tachycardia found on ICD interrogation: relationship of RR-NSVT to outcomes in the SCD-HeFT trial

Representativeness of RELAX-AHF clinical trial population in acute heart failure.

Response by Hess et al to Letter Regarding Article, “Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Fai

Response to Letter Regarding Article, "Comparative Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention in Women".

Response to Letter Regarding Article, “Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure: Analysis From the Sudden Cardiac Death in Heart Failure Trial”

Response to Letter Regarding Article, “Risk of Thromboembolism in Heart Failure: An Analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)”

Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation".

Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure

Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention

Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings from the Get With The Guidelines-Heart Failure Program

Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)

Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials

Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study

The association of pre- and posthospital medication adherence in myocardial infarction patients

Thyroid function in heart failure and impact on mortality

Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention

Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atr

Treatment, Outcomes, and Adherence to Medication Regimens Among Dual Medicare-Medicaid-Eligible Adults With Myocardial Infarction

Trends in use of implantable cardioverter-defibrillator therapy among patients hospitalized for heart failure: have the previously observed sex and racial disparities changed over time?

Unexpected deviation in circadian variation of ventricular arrhythmias: the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial

Use and predictors of heart failure disease management referral in patients hospitalized with heart failure: insights from the Get With the Guidelines Program

Use of Prescription Smoking Cessation Medications After Myocardial Infarction Among Older Patients in Community Practice

Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial